Switch to:
More From Other Websites
Medicare Coverage of Prolaris® Test Expands with the Addition of Men Diagnosed with Favorable... May 25 2017
Edited Transcript of MYGN earnings conference call or presentation 2-May-17 8:30pm GMT May 23 2017
ETFs with exposure to Myriad Genetics, Inc. : May 22, 2017 May 22 2017
Myriad Genetics to Present Seven Studies at the 2017 American Society of Clinical Oncology Annual... May 18 2017
Myriad Genetics’ Prolaris® Test Accurately Predicts the 10-Year Risk of Metastases in Men Treated... May 12 2017
Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 8, 2017 May 08 2017
Don’t Give Up on Buybacks Just Yet May 07 2017
Myriad Genetics to Present Results from Four Studies at the American Urological Association 2017... May 05 2017
Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : May 4, 2017 May 04 2017
Here's Why Myriad Genetics Rose as Much as 16% This Morning May 03 2017
Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma May 03 2017
Myriad Genetics (MYGN) Tops Q3 Earnings & Sales, Tweaks View May 03 2017
Myriad tops Street 3Q forecasts May 02 2017
Myriad Genetics shares jump on earnings beat, outlook May 02 2017
Myriad Genetics and Clovis Oncology Sign Agreement for Use of FDA-Approved BRACAnalysis CDx® Test... Apr 27 2017
Can Myriad Genetics (MYGN) Spring a Surprise in Q3 Earnings? Apr 24 2017
Myriad to Announce Fiscal Third-Quarter 2017 Financial Results on May 2, 2017 Apr 18 2017
Myriad Genetics, Inc. – Value Analysis (NASDAQ:MYGN) : April 17, 2017 Apr 17 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)